Compare Nvidia Corp (NVDA) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nvidia Corp vs Zoetis Inc — how do they compare? Nvidia Corp trades at $229.28 (market cap $5.57T), while Zoetis Inc trades at $74.77 (market cap $30.20B). The key difference: Nvidia Corp is far larger — about 184.4× Zoetis Inc's market cap, and Zoetis Inc pays the higher dividend (2.9%). Which is the better fit depends on your goals — on Pluang, investors hold Nvidia Corp for 115 Days and Zoetis Inc for 70 Days on average.
| NVDA | ZTS | |
|---|---|---|
Market Cap | $5.57T | $30.20B |
Volume | 117,720,595 | 6,175,327 |
Sector | Technology | Health |
52-Week High | $239.27 | $147.53 |
52-Week Low | $165.17 | $69.09 |
Typical Hold Time | 115 Days | 70 Days |
Enterprise Value | $5.54T | $37.76B |
Dividend Yield | 0.43% | 2.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NVIDIA (NVDA) trades at $230.48, down 2.9% on the day, with strong technical support at $228 and resistance at $235. The company demonstrates exceptional fundamental strength with 2025 revenue of $130.5B and net income of $72.9B, achieving a 55.84% profit margin. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $2.22 exceeding the $2.09 forecast. Analyst consensus remains strongly bullish with a $339.17 price target representing 47% upside potential from current levels.
NVIDIA's AI leadership and accelerating revenue growth position it for continued outperformance, though investors face risks from increased competition and market volatility. The stock's current valuation metrics (P/E 29.14, P/S 18.56) reflect premium pricing justified by exceptional profitability and market dominance in AI infrastructure. Institutional sentiment remains positive despite recent profit-taking by some funds.
Zoetis (ZTS) trades at $73.08, up 2.14% today, with a bullish technical signal but mixed earnings history including a recent Q1 2026 miss. The stock shows strong profitability with a 27.69% net income margin and 64.91% ROE, while valuation metrics like a P/E of 11.92 appear reasonable. Recent news highlights competitive pressures in the U.S. pet care market, though international segments remain resilient.
The outlook is cautiously optimistic; ZTS faces near-term headwinds from weak U.S. demand and competition, but its industry-leading margins and dominant market position support long-term growth. Risks include pricing erosion and guidance cuts, yet the consensus price target of $87.33 suggests upside potential for patient investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nvidia Corp
NVIDIA Corporation designs, develops, and markets three dimensional (3D) graphics processors and related software. The Company offers products that provides interactive 3D graphics to the mainstream personal computer market.
Read more on NVDA →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
